Statements (51)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
muscle relaxant
|
| gptkbp:approves |
gptkb:FDA
|
| gptkbp:availableIn |
generic drug
|
| gptkbp:brand |
gptkb:Robaxin
|
| gptkbp:chemicalFormula |
liver
C11H15N2O5 |
| gptkbp:clinicalTrials |
Phase IV
|
| gptkbp:commonName |
1000 mg
750 mg 1500 mg |
| gptkbp:contraindication |
allergy to methocarbamol
|
| gptkbp:drugInterdiction |
muscle relaxants
skeletal muscle relaxants |
| gptkbp:formulation |
tablet
oral suspension injection solution |
| https://www.w3.org/2000/01/rdf-schema#label |
Methocarbamol
|
| gptkbp:interactsWith |
alcohol
CNS depressants |
| gptkbp:isATypeOf |
532-04-9
|
| gptkbp:isRecognizedFor |
pregnant women
children under 12 patients with severe renal impairment nursing mothers patients with liver disease |
| gptkbp:issuedBy |
injection
oral tablet |
| gptkbp:isUtilizedIn |
urine
|
| gptkbp:lastProduced |
1957
|
| gptkbp:offersCoursesIn |
gptkb:Australia
gptkb:Brazil gptkb:Canada gptkb:France gptkb:Germany gptkb:India gptkb:Japan gptkb:Mexico gptkb:United_Kingdom gptkb:United_States |
| gptkbp:sideEffect |
dizziness
fatigue headache nausea vomiting confusion drowsiness dry mouth blurred vision hypotension |
| gptkbp:triggerType |
central nervous system depressant
|
| gptkbp:usedFor |
muscle spasms
|